Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Thursday, September 2, 1999 Published at 18:17 GMT 19:17 UK


Health

Drug to combat growing malaria menace

Malaria is spread by mosquitoes

A cheap drug that can be taken orally may provide an effective new way to treat malaria - a disease which is becoming resistant to current medications.


BBC Science Correspondent Christie McGourty: "Drug could be a significant breakthrough"
The drug appears to cure the rodent version of malaria in mice, and scientists hope it will also work in humans.

A new treatment is urgently needed for a disease which is one of the leading causes of sickness in the tropics, responsible for up to 2.7 million deaths per year.

There is also concern that because of global warming malaria will spread to temperate climates, including the UK.

Nearly all fatal cases are caused by a parasite called Plasmodium falciparum.

The organism is rapidly becoming resistant to conventional antimalarial drugs such as chloroquine.

Crucial enzyme

A team of German scientists report in the journal Science that they have indentified an enzyme in the parasite that plays a key role in the manufacture of substances linked to the development of malaria symptoms.

They showed that two drugs, fosmidomycin and FR-900089, were able to shut down the activity of the enzyme in mice infected with the rodent version of the parasite.

Mice treated with the drugs over a perid of eight days were totally cured.

Growth of a multidrug-resistant form of the human parasite was also blocked by the drugs under laboratory conditions.

The authors write: "The efficacy of these drugs against multidrug-resistant parasites and their low manufacturing costs and high stability make them very attractive as a potential new class of antimalarial drugs."

Fosmidomycin is already being used to treat bacterial infections in humans and is known to be safe.

However, one drawback is that to cure the mice, the drug had to be administered three times a day for a week, so it may be that a stronger drug is needed to be effective in humans.

The researchers hope to begin clinical trials in the next few months and a treatment could be available within three years.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

17 Jun 99 | Medical notes
Infectious disease: A guide

15 Jun 99 | Health
'Medieval' diseases on the comeback

04 Jun 99 | Health
Doctors urge two-pronged attack on malaria

30 Mar 99 | Health
Malaria 'kills hospital patient'

16 Feb 99 | Health
Malaria targeted by gene vaccine





Internet Links


Malaria Foundation International

Malaria

Science


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99